Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study (Q84827700)
Jump to navigation
Jump to search
scientific article published on 01 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study |
scientific article published on 01 August 2012 |
Statements
Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study (English)